Integrated Proteomic and Metabolomic Profiling Reveals Impaired Mitochondrial Oxidative Phosphorylation in Hypertrophic Cardiomyopathy
Structural and Congenital Heart Disease · 2026 · 1-10
DOI: 10.32604/schd.2026.077380 ↗Kurz gefasst
Fachartikel in der Zeitschrift Structural and Congenital Heart Disease, 2026. Verfasst von Meng-Zhen Zhang und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhang, M., Li, M., Wen, P., Wu, Y., & Sun, L. (2026). Integrated Proteomic and Metabolomic Profiling Reveals Impaired Mitochondrial Oxidative Phosphorylation in Hypertrophic Cardiomyopathy. Structural and Congenital Heart Disease, 0(0), 1-10. https://doi.org/10.32604/schd.2026.077380
Vancouver
Zhang M, Li M, Wen P, Wu Y, Sun L. Integrated Proteomic and Metabolomic Profiling Reveals Impaired Mitochondrial Oxidative Phosphorylation in Hypertrophic Cardiomyopathy. Structural and Congenital Heart Disease. 2026;0(0):1-10. doi:10.32604/schd.2026.077380
BibTeX
@article{Zhang2026,
author = {Zhang, Meng-Zhen and Li, Ming and Wen, Peng-Ju and Wu, Yue-Heng and Sun, Ling},
title = {Integrated Proteomic and Metabolomic Profiling Reveals Impaired Mitochondrial Oxidative Phosphorylation in Hypertrophic Cardiomyopathy},
journal = {Structural and Congenital Heart Disease},
year = {2026},
volume = {0},
number = {0},
pages = {1--10},
doi = {10.32604/schd.2026.077380}
}
EUVIMED